未控制的高血压与腹主动脉瘤腔内修复术后并发症及较差结局相关
基于血管质量倡议(VQI)2020至2023年数据,纳入接受择期腹主动脉瘤腔内修复(EVAR)的患者,比较无高血压史、控制良好高血压(cHTN)和未控制高血压(uHTN)三组的围术期结局。多变量分析显示,uHTN组围术期死亡风险(aOR 2.64)和ICU延长停留风险(aOR 1.52)高于无高血压组;cHTN组围术期死亡(aOR 0.60)、心脏并发症(aOR 0.60)和ICU延长停留(aOR 0.55)风险低于uHTN组;cHTN组与无高血压组结局无显著差异。
要点
- uHTN组围术期死亡风险高于无高血压组(aOR 2.64,95%CI 1.44-4.88,P=.002)。
- cHTN组围术期死亡风险低于uHTN组(aOR 0.60,95%CI 0.38-0.96,P=.029)。
- cHTN组与无高血压组围术期死亡率和院内并发症无显著差异。
核心结论
- uHTN患者较无高血压和cHTN患者更可能发生围术期死亡、心脏并发症和ICU延长停留等较差结局。
- cHTN患者结局与无高血压患者相似。
- 作者认为这些结果强调在择期EVAR前调控血压以改善患者整体结局的重要性。
- 作者指出进一步研究可能为EVAR前最佳血压控制时长提供更多见解。
研究设计与样本
- 基于血管质量倡议(VQI)数据库2020至2023年接受EVAR的患者进行分析。
- 患者分为三组:无高血压史组11938例(34.6%)、cHTN组17926例(52.0%)、uHTN组4598例(13.3%)。
- 高血压定义依据记录的高血压病史或术前三次以上测量的血压。
- cHTN定义为接受药物治疗且血压<130/80;uHTN定义为血压>130/80。
- 主要结局为围术期死亡;次要结局包括心肌梗死及其他心脏并发症、肺部并发症、肠和腿缺血、急性肾损伤及ICU延长停留(>1天)。
主要发现
- cHTN和uHTN组较无高血压组有更高的合并症率,包括既往冠状动脉疾病、糖尿病和充血性心力衰竭,且更可能接受阿司匹林和他汀治疗。
- uHTN组较无高血压组围术期死亡风险更高(aOR 2.64,95%CI 1.44-4.88,P=.002),ICU延长停留风险更高(aOR 1.52,95%CI 1.25-1.83,P<.001)。
- cHTN组较uHTN组围术期死亡风险更低(aOR 0.60,95%CI 0.38-0.96,P=.029),心脏并发症风险更低(aOR 0.60,95%CI 0.38-0.99,P=.036),ICU延长停留风险更低(aOR 0.55,95%CI 0.46-0.66,P<.001)。
- cHTN组与无高血压史组围术期死亡率和院内并发症无显著差异。
临床怎么用
- 作者认为这些结果强调在择期EVAR前调控血压以改善患者整体结局的重要性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hypertension (HTN) has been well-documented as a strong predictive factor for worse outcomes in patients undergoing various cardiovascular procedures. However, limited research has investigated the effect of controlled vs uncontrolled HTN (uHTN) preoperatively in patients undergoing elective endovascular aneurysm repair (EVAR). Using a national database, we aimed to determine whether there are significant differences in outcomes between these two groups to improve quality of care and preoperative management. METHODS: We studied patients undergoing EVAR in the Vascular Quality Initiative from 2020 to 2023. Patients were categorized into three groups: no history of HTN, controlled HTN (cHTN), and uHTN. The definition of HTN in this study was based on documented history of HTN or recorded blood pressures on three or more occasions before the procedure. Patients with cHTN included patients treated with medication and having a blood pressure of <130/80. Patients with uHTN had a blood pressure of >130/80. Our primary outcome was perioperative death. Secondary outcomes included myocardial infarction and other cardiac complications, pulmonary complications, bowel and leg ischemia, acute kidney injury, and prolonged intensive care unit (ICU) length of stay (LOS) (>1 day). We used logistic regression models for a multivariate analysis, controlling for confounding variables. RESULTS: A total of 11,938 patients without HTN (34.6%) , 17,926 patients with cHTN (52.0%) , and 4598 patients with uHTN (13.3%) were analyzed. Patients with cHTN and uHTN had higher rates of comorbidities, including prior coronary artery disease, diabetes, and congestive heart failure and were more likely receiving aspirin and statin compared with patients with no HTN. In the multivariate analysis, patients with uHTN had higher risk of perioperative death (adjusted odd ratio [aOR], 2.64; 95% confidence interval [CI], 1.44-4.88; P = .002), and prolonged ICU LOS (aOR, 1.52; 95% CI, 1.25-1.83; P < .001) compared with patients without HTN. Patients with patients with cHTN had a significantly lower rate of perioperative death (aOR, 0.60; 95% CI, 0.38-0.96; P = .029), cardiac complications (aOR, 0.60; 95% CI, 0.38-0.99; P = .036), and prolonged ICU LOS (aOR, 0.55; 95% CI, 0.46-0.66; P < .001) compared with patients with uHTN. Notably, there was no significant difference in perioperative mortality or in-hospital complications between patients with cHTN and those with no history of HTN. CONCLUSIONS: Patients with uHTN are more likely to experience worse outcomes-including perioperative death, cardiac complications, and prolonged ICU stay-compared with patients with no HTN and those with cHTN. Patients with cHTN had similar outcomes to patients with no HTN. These results highlight the importance of regulating blood pressures before undergoing elective EVAR to improve patients' overall outcomes. Further studies may add more insight into the optimal duration of blood pressure control before EVAR.
引用
- Straus S, Farah M, Pillai K, et al. Uncontrolled hypertension is associated with complications and poorer outcomes after endovascular aneurysm repair. J Vasc Surg. 2024. PMID: 39617079. doi:10.1016/j.jvs.2024.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。